EV/EBITDA
-8.90
+0.36+3.89%
Thu, 13 Mar 2025 20:05:06 GMT
Summary
- As of March 14, 2025, ELVN EV/EBITDA is -8.90, with a rise of +0.36 (+3.89%) during the most recent trading day.
- Over the past year, ELVN EV/EBITDA has dropped by -5.04 (-130.57%).
- ELVN EV/EBITDA is now -134.21% below its all-time high of -3.80.
Performance
ELVN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ELVN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.9% | -3.9% | -3.5% |
| 1 m1 month | +6.2% | -6.2% | -5.6% |
| 3 m3 months | +13.6% | -13.6% | -12.3% |
| 6 m6 months | +9.6% | -7.0% | -9.1% |
| ytdytd | +10.8% | -10.8% | -9.8% |
| 1 y1 year | -130.6% | +148.5% | +65.4% |
| 5 y5 years | - | - | +26.8% |
ELVN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.9% | -9.69 | +8.2% | |
| 3 m | 3-month | -8.57 | -3.9% | -10.92 | +18.5% |
| 6 m | 6-month | -8.57 | -3.9% | -13.42 | +33.7% |
| 1 y | 1-year | -3.80 | -134.2% | -13.42 | +33.7% |
| 3 y | 3-year | -3.80 | -134.2% | -23.53 | +62.2% |
| 5 y | 5-year | -3.80 | -134.2% | -23.53 | +62.2% |
| alltime | all time | -3.80 | -134.2% | -23.53 | +62.2% |
Enliven Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.90(-10.8%) |
| Date | Value |
|---|---|
| 2024 | -9.98(+70.6%) |
| 2023 | -5.85 |
FAQ
- What is Enliven Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Enliven Therapeutics?
- What is ELVN EV/EBITDA year-to-date change?
- What is Enliven Therapeutics EV/EBITDA year-on-year change?
What is Enliven Therapeutics EV/EBITDA?
The current EV/EBITDA of ELVN is -8.90
What is the all time high EV/EBITDA for Enliven Therapeutics?
Enliven Therapeutics all-time high EV/EBITDA is -3.80
What is ELVN EV/EBITDA year-to-date change?
Enliven Therapeutics EV/EBITDA has changed by +1.08 (+10.82%) since the beginning of the year
What is Enliven Therapeutics EV/EBITDA year-on-year change?
Over the past year, ELVN EV/EBITDA has changed by -5.04 (-130.57%)